KUKJEON Co.,Ltd (KOSDAQ:307750)
2,670.00
-55.00 (-2.02%)
At close: Oct 14, 2026
KUKJEON Co.,Ltd Revenue
KUKJEON Co.,Ltd had revenue of 40.48B KRW in the quarter ending June 30, 2026, with 21.43% growth. This brings the company's revenue in the last twelve months to 134.57B, down -0.37% year-over-year. In the year 2025, KUKJEON Co.,Ltd had annual revenue of 131.04B, down -3.98%. That makes KUKJEON Co.,Ltd the 22,584th largest company in the world by revenue and 1,262nd in South Korea.
Revenue (ttm)
134.57B
Revenue Growth
-0.37%
P/S Ratio
1.07
Revenue / Employee
782.40M
Employees
172
Market Cap
144.14B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 131.04B | -5.43B | -3.98% |
| Dec 31, 2024 | 136.47B | 14.47B | 11.86% |
| Dec 31, 2023 | 122.00B | 18.29B | 17.63% |
| Dec 31, 2022 | 103.71B | 18.36B | 21.51% |
| Dec 31, 2021 | 85.35B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Aurora World | 359.90B |
| Kyung Dong Pharmaceutical | 201.12B |
| Eco&Dream | 108.69B |
| T3 Entertainment | 81.68B |
| Orbitech | 68.29B |
| JI-Tech | 66.70B |
| ELC Co.,Ltd. | 47.41B |
| L&K Biomed | 39.94B |